134 related articles for article (PubMed ID: 3140769)
1. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.
Carlson SE; Aldrich MS; Greenberg HS; Topol EJ
Arch Neurol; 1988 Oct; 45(10):1070-3. PubMed ID: 3140769
[TBL] [Abstract][Full Text] [Related]
2. Ruptured arteriovenous malformation complicating thrombolytic therapy with tissue plasminogen activator.
Proner J; Rosenblum BR; Rothman A
Arch Neurol; 1990 Jan; 47(1):105-6. PubMed ID: 2104746
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
Da Silva VF; Bormanis J
Neurosurgery; 1992 Jun; 30(6):943-5. PubMed ID: 1614602
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction.
del Zoppo GJ; Copeland BR; Anderchek K; Hacke W; Koziol JA
Stroke; 1990 Apr; 21(4):596-601. PubMed ID: 2109375
[TBL] [Abstract][Full Text] [Related]
5. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.
Kase CS; O'Neal AM; Fisher M; Girgis GN; Ordia JI
Ann Intern Med; 1990 Jan; 112(1):17-21. PubMed ID: 2104561
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML
Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral hematoma related to thrombolysis for myocardial infarction.
Kaufman HH; McAllister P; Taylor H; Schmidt S
Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
[TBL] [Abstract][Full Text] [Related]
9. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
10. An autopsy case of intracranial hemorrhage during tissue plasminogen activator infusion.
Masuoka H; Kotani H; Yazu T; Mizuno O; Miyahara M; Sekoguchi K; Tanaka R; Ueda K; Fukui A; Futagami Y
Heart Vessels; 1993; 8(3):163-5. PubMed ID: 8407727
[TBL] [Abstract][Full Text] [Related]
11. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset.
Haley EC; Levy DE; Brott TG; Sheppard GL; Wong MC; Kongable GL; Torner JC; Marler JR
Stroke; 1992 May; 23(5):641-5. PubMed ID: 1579959
[TBL] [Abstract][Full Text] [Related]
12. Danger of treatment protocols.
Cucchiara B; Messé S; Kasner SE
Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
[No Abstract] [Full Text] [Related]
13. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
14. An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction.
Chang GY
Eur J Neurol; 2001 May; 8(3):267-8. PubMed ID: 11328336
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.
von Kummer R; Hacke W
Stroke; 1992 May; 23(5):646-52. PubMed ID: 1579960
[TBL] [Abstract][Full Text] [Related]
16. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
[TBL] [Abstract][Full Text] [Related]
17. Mental Dullness after thrombolytic therapy.
Woo KS; Chan HC; Poon WS
Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
[No Abstract] [Full Text] [Related]
18. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
[TBL] [Abstract][Full Text] [Related]
19. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
